Company Filing History:
Years Active: 1997-2005
Title: The Innovations of Fritz Benseler
Introduction
Fritz Benseler is a notable inventor based in Gleichen/Etzborn, Germany. He has made significant contributions to the field of RNA technology, holding a total of 4 patents. His work focuses on modified ribozymes, which have important implications for therapeutic applications.
Latest Patents
Benseler's latest patents include innovative RNA molecules with catalytic activity. One of his inventions refers to an RNA molecule that comprises at least one modified nucleoside, where the hydroxy group at the 2'-position of the ribose sugar is replaced by a modifier group. This modifier group can be selected from halo, sulfhydryl, azido, amino, monosubstituted amino, and disubstituted amino groups. The invention also details a process for preparing these modified RNA molecules and their use as therapeutic agents and biocatalysts. Another patent focuses on RNA molecules with similar catalytic activity, emphasizing the use of modifier groups that replace the hydroxy group at the 2'-position of the ribose sugar.
Career Highlights
Fritz Benseler is associated with the Max Planck Society for the Advancement of Science, a prestigious research institution in Germany. His work has been instrumental in advancing the understanding and application of RNA technology.
Collaborations
Benseler has collaborated with notable scientists in his field, including Fritz Eckstein and Wolfgang A. Pieken. These collaborations have contributed to the depth and breadth of his research.
Conclusion
Fritz Benseler's innovative work in RNA technology and his contributions to the field through his patents highlight his role as a significant inventor. His research continues to pave the way for advancements in therapeutic applications and biocatalysis.